Evidence map›Paper›PMID 34762814›Full record

ArticleJournal of speech, language, and hearing research : JSLHR2021

"You Say Severe, I Say Mild": Toward an Empirical Classification of Dysarthria Severity.

Kaila L Stipancic, Kira M Palmer, Hannah P Rowe, Yana Yunusova, James D Berry, Jordan R Green

Open access · greenAbstract read
In one paragraph

Article in Journal of speech, language, and hearing research : JSLHR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Perceptual Outcome Measures for Supplementing Transcription Intelligibility in Speakers with Parkinson's Disease and Mild Dysarthria.Folia phoniatrica et logopaedica : official organ of the International Association of Logopedics and Phoniatrics (IALP) · 2026
    Article
  8. Article
  9. Article
  10. Automated Scoring of the Speech Intelligibility Test Using Autoscore.American journal of speech-language pathology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Tipping the Scales: Indiscriminate Use of Interval Scales to Rate Diverse Dysarthric Features.Journal of speech, language, and hearing research : JSLHR · 2024
    Article
  18. Article
  19. Effects of Deep-Brain Stimulation on Speech: Perceptual and Acoustic Data.Journal of speech, language, and hearing research : JSLHR · 2024
    Article
  20. Sex Differences in the Speech of Persons With and Without Parkinson's Disease.American journal of speech-language pathology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Kaila L StipancicDepartment of Communicative Disorders and Sciences, University at Buffalo, NY.ORCID 0000-0001-5185-563X
Kira M PalmerDepartment of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA.
Hannah P RoweDepartment of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA.ORCID 0000-0002-8788-347X
Yana YunusovaDepartment of Speech-Language Pathology, University of Toronto, Ontario, Canada.ORCID 0000-0002-2353-2275
James D BerrySean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Boston.
Jordan R GreenDepartment of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA.ORCID 0000-0002-1464-1373
Google (United States) · US

Funding

The Harvard Clinical and Translational Science CenterUL1TR002541 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2018 to 2022
$93.0M
The development and validation of a novel tool for the assessment of bulbar dysfunction in ALSR01DC017291 · NIDCD · SUNNYBROOK RESEARCH INSTITUTE · PI JORDAN R GREEN, Yana Yunusova · 2018 to 2026
$3.6M
SPEECH MOVEMENT CLASSIFICATION FOR ASSESSING AND TREATING ALSR01DC013547 · NIDCD · MGH INSTITUTE OF HEALTH PROFESSIONS · PI GREEN, JORDAN R · 2014 to 2018
$3.2M
Bulbar Motor Deterioration in ALSR01DC009890 · NIDCD · UNIVERSITY OF NEBRASKA LINCOLN · PI GREEN, JORDAN R, YUNUSOVA, YANA · 2009 to 2013
$2.3M
Prolonging Functional Speech in Persons with Amyotrophic Lateral Sclerosis: A Real-Time Virtual Vocal TractK24DC016312 · NIDCD · MGH INSTITUTE OF HEALTH PROFESSIONS · PI GREEN, JORDAN R · 2017 to 2021
$949k
NCATS NIH HHS UL1 TR002541NIDCD NIH HHS K24 DC016312NIDCD NIH HHS R01 DC009890NIDCD NIH HHS R01 DC013547NIDCD NIH HHS R01 DC017291
6 · The paper itself

Abstract

purposeThe main purpose of this study was to create an empirical classification system for speech severity in patients with dysarthria secondary to amyotrophic lateral sclerosis (ALS) by exploring the reliability and validity of speech-language pathologists' (SLPs') ratings of dysarthric speech.

methodTen SLPs listened to speech samples from 52 speakers with ALS and 20 healthy control speakers. SLPs were asked to rate the speech severity of the speakers using five response options: normal, mild, moderate, severe, and profound. Four severity-surrogate measures were also calculated: SLPs transcribed the speech samples for the calculation of speech intelligibility and rated the effort it took to understand the speakers on a visual analog scale. In addition, speaking rate and intelligible speaking rate were calculated for each speaker. Intrarater and interrater reliability were calculated for each measure. We explored the validity of clinician-based severity ratings by comparing them to the severity-surrogate measures. Receiver operating characteristic (ROC) curves were conducted to create optimal cutoff points for defining dysarthria severity categories.

resultsIntrarater and interrater reliability for the clinician-based severity ratings were excellent and were comparable to reliability for the severity-surrogate measures explored. Clinician severity ratings were strongly associated with all severity-surrogate measures, suggesting strong construct validity. We also provided a range of values for each severity-surrogate measure within each severity category based on the cutoff points obtained from the ROC analyses.

conclusionsClinician severity ratings of dysarthric speech are reliable and valid. We discuss the underlying challenges that arise when selecting a stratification measure and offer recommendations for a classification scheme when stratifying patients and research participants into speech severity categories.

Indexed as

DysarthriaSpeech PerceptionHumansReproducibility of ResultsSpeech IntelligibilitySpeech Production Measurement

Identifiers

PMID34762814
PMCPMC9150682
OpenAlexW3214266918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.